ClinicalTrials.gov
public full text
Public Domain
Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab
head-and-neck-squamous-cell-carcinomamelanomanon-small-cell-lung-cancerrenal-cell-carcinomasolid-tumor
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related documents
- Post-ATU Study of Nivolumab#28315
- Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy#1171262
- Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC#850444
- Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery#272336
- A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread#1173019
Record · ID 369832 · SHA-256 66ba04e716eacfbd
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive